Gilead Sciences, Inc. Recalls

All product recalls associated with Gilead Sciences, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

7

Past Year

0

Class I (Serious)

3

Most Recent

Sep 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–7 of 7 recalls

Veklury Injection (Gilead) – Glass Particle Contamination (2024)

Presence of Particulate Matter: Presence of glass particle.

Class IHigh

FDASep 19, 2024Nationwide• Gilead Sciences, Inc.

Veklury (Gilead) - Glass Particulate Contamination (2021)

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Class IHigh

FDADec 3, 2021Nationwide• Gilead Sciences, Inc.

Emtriva Oral Solution (Gilead) – Leaking Container (2014)

Defective Container; leaking around the cap

Class II

Moderate

FDAOct 1, 2014Nationwide• Gilead Sciences, Inc.

Truvada Tablets (Gilead) – Foreign Substance (2014)

Presence of Foreign Substance: Truvada was found to contain small red silicone rubber particulates.

Class IIILow

FDASep 30, 2014Nationwide• Gilead Sciences, Inc.

Atripla (Gilead) – Foreign Substance Risk (2014)

Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.

Class IIILow

FDAFeb 19, 2014Nationwide• Gilead Sciences, Inc.

AmBisome (Gilead Sciences) – sterility concern (2013)

Lack of Sterility Assurance; During a routine simulation of the manufacturing of AmBisome, a bacterial contamination was detected in some media fill units. No contaminated batches have actually been identified in the finished product, but there is a possibility of contamination.

Class IIModerate

FDAJun 20, 2013Nationwide• Gilead Sciences, Inc.